Profil
Holger Lembrér is currently Chief Financial Officer at Enzymatica AB since 2026.
Formerly, Chief Financial Officer at Boule Diagnostics AB from 2024 to 2026, Chief Financial Officer at Oncopeptides AB in 2023, Chief Financial Officer at ASSA ABLOY.
AB from 2011 to 2019, and Auditor at Ernst & Young AB from 2008 to 2011.
Education includes a graduate degree from the University of Uppsala.
Aktuelle Nachrichten zu Holger Lembrér
Aktive Positionen von Holger Lembrér
| Unternehmen | Position | Beginn |
|---|---|---|
| ENZYMATICA AB | Finanzdirektor/CFO | 13.04.2026 |
Ehemalige bekannte Positionen von Holger Lembrér
| Unternehmen | Position | Ende |
|---|---|---|
| BOULE DIAGNOSTICS AB | Vorstandsvorsitzender | 16.04.2024 |
| ONCOPEPTIDES AB | Finanzdirektor/CFO | 13.11.2023 |
| ASSA ABLOY AB | Finanzdirektor/CFO | 01.04.2019 |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Comptroller/Controller/Auditor | 01.09.2011 |
Ausbildung von Holger Lembrér
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Assa Abloy AB
Assa Abloy AB Tools & HardwareConsumer Durables Manufactures and sells mechanical, electromechanical, digital door locks and smart home access solutions | Consumer Durables |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Boule Diagnostics AB
Boule Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical tools | Health Technology |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Commercial Services |
Enzymatica AB
Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
















